BackPURE Bioscience Overview

PURE Bioscience Receivables

Track PURE Bioscience's receivables ($240K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$242000.00
↓ 15.68% YoYΔ $-45000.00 vs prior year quarter

Peer trimmed avg / median

Loading

PURE Bioscience Receivables History

Loading

PURE Bioscience vs. peers: Receivables Comparison

Loading

PURE Bioscience Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

PURE Bioscience (PURE) FAQ

As of the most recent data (April 2026), PURE shows a receivables of $240K. That compares with $290K in the prior-year period — down 15.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PURE's receivables is now $240K (was $290K) — a 15.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether PURE Bioscience is outperforming or lagging.

Tracking PURE's receivables over time shows whether PURE Bioscience is scaling, shrinking, or reshaping that part of the business. The current reading is $240K That compares with $290K in the prior-year period — down 15.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has PURE Bioscience's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $240K) with ownership activity and broader fundamentals.